Mostrar el registro sencillo del ítem
dc.contributor.author
Vinderola, Celso Gabriel
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.contributor.author
Druart, Céline
dc.contributor.author
Gosálbez, Luis
dc.contributor.author
Salminen, Seppo
dc.contributor.author
Vinot, Nina
dc.contributor.author
Lebeer, Sarah
dc.date.available
2024-08-27T15:18:42Z
dc.date.issued
2023-09
dc.identifier.citation
Vinderola, Celso Gabriel; Druart, Céline; Gosálbez, Luis; Salminen, Seppo; Vinot, Nina; et al.; Postbiotics in the medical field under the perspective of the ISAPP definition: scientific, regulatory, and marketing considerations; Frontiers Media; Frontiers in Pharmacology; 14; 9-2023; 1-6
dc.identifier.issn
1663-9812
dc.identifier.uri
http://hdl.handle.net/11336/243198
dc.description.abstract
Diverse terms have been used in the literature to refer to the health benefitsobtained from the administration of non-viable microorganisms or their cellfragments and metabolites. In an effort to provide continuity to this emergingfield, the International Scientific Association of Probiotics and Prebiotics (ISAPP)convened a panel of experts to consider this category of substances and adoptedthe term postbiotic, which they defined as a “preparation of inanimatemicroorganisms and/or their components that confers a health benefit on thehost.” This definition does not stipulate any specific health benefit, finishedproduct, target population or regulatory status. In this perspective article, wefocused on postbiotics developed for pharmaceutical uses, including medicinalproducts and medical devices. We address how this field is regulated for productsbased on inanimate microorganisms, marketing considerations and existingexamples of postbiotics products developed as cosmetics for the skin, forvaginal health, and as orally consumed products. We focus on the EuropeanUnion for regulatory aspects, but also give examples from other geographicalareas.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Frontiers Media
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
postbiotics
dc.subject
International Scientific Association for Probiotics and Prebiotics
dc.subject
ISAPP
dc.subject
medicinal product
dc.subject
medical device
dc.subject
drug
dc.subject.classification
Alimentos y Bebidas
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Otras Ingenierías y Tecnologías
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
INGENIERÍAS Y TECNOLOGÍAS
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Postbiotics in the medical field under the perspective of the ISAPP definition: scientific, regulatory, and marketing considerations
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2024-08-26T10:56:32Z
dc.journal.volume
14
dc.journal.pagination
1-6
dc.journal.pais
Estados Unidos
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.description.fil
Fil: Vinderola, Celso Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
dc.description.fil
Fil: Druart, Céline. Pharmabiotic Research Institute; Francia
dc.description.fil
Fil: Gosálbez, Luis. No especifíca;
dc.description.fil
Fil: Salminen, Seppo. University Of Turku; Finlandia
dc.description.fil
Fil: Vinot, Nina. No especifíca;
dc.description.fil
Fil: Lebeer, Sarah. Universiteit Antwerp; Bélgica
dc.journal.title
Frontiers in Pharmacology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1239745/full
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3389/fphar.2023.1239745
Archivos asociados